News
38mon MSN
The child will need to be monitored throughout his life, but researchers said the treatment’s success indicates that other ...
Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, presented data on two therapeutic applications of its genome editing and ...
CRISPR-Cas9 is a powerful gene editing system that has revolutionized our ability to treat disease and probe the human genome. CRISPR has been used to edit the genomes of animals, plants, and microbes ...
This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.
While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...
Applied StemCell, a CRO/CDMO that blends unique genome editing technology and iPSC expertise, announced the launch of their first hypoimmunogenic hiPSC products which are designed to empower ...
Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor ...
Modern Engineering Marvels on MSN2d
evoCAST: A Leap Forward in Precision Gene Editing Promises a New Era for Genetic TherapiesMobile genetic elements such as CAST provide an idea of the coding potential of nature for genome manipulation. It is in the ...
Over the past decade, lipid nanoparticles (LNPs) have become a cornerstone in the field of nucleic acid delivery, with applications extending from vaccines ...
Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...
The Cambridge biotech's wild ambitions for a powerful gene editing technology sank as the biotech market slumped.
Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. | Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results